These results, together with a previous report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assistance the idea of targeting ACKR3 as a novel way to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Diseases. These benefits recommend that conolidine is https://juliee416lsz6.blog-eye.com/profile